Mumbai, Oct.9 Drug-maker GlaxoSmithKline is setting up a new manufacturing line at Nashik as part of its global corporate social responsibility, contributing towards world-wide efforts to tackle Lymphatic Filariasis by 2020. The new production line will deliver an additional 300 million treatments of albendazole per year, in what is being seen as among the largest drug donations in the global pharmaceutical industry, a GSK note said. The facility will start production in late 2008 and will double GSK’s current global albendazole capacity. The drug-maker will invest about £2,00,000 in the additional line, besides converting existing equipment...
[read full story]
Your Web Site
